| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/31/2023 | Beyond Air, Inc. | XAIR | Purchase | Common Stock | 5k | $6.67 | $33.4k | | 03/31/2023 |
| 03/29/2023 | Beyond Air, Inc. | XAIR | Grant | Stock Option (right to buy) | 40k | $6.28 | $251.2k | | 03/29/2023 |
| 03/17/2023 | Beyond Air, Inc. | XAIR | Purchase | Common Stock | 5k | $6.46 | $32.3k | | 03/17/2023 |
| 06/29/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Performance Stock Options (right to buy) | 48k | $3.21 | $154.1k | | 06/29/2022 |
| 03/03/2022 | Beyond Air, Inc. | XAIR | Grant | Stock Option (right to buy) | 30k | $6.87 | $206.1k | | 03/03/2022 |
| 02/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 137.5k | $0.51 | $70.3k | | 02/11/2022 |
| 02/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 137.5k | $0.51 | $70.3k | | 02/11/2022 |
| 03/04/2021 | Beyond Air, Inc. | XAIR | Grant | Stock Option (right to buy) | 25k | $5.45 | $136.2k | | 03/04/2021 |
| 02/01/2021 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 200k | $3.03 | $606k | | 02/01/2021 |
| 06/03/2019 | Beyond Air, Inc. | XAIR | Purchase | Common Stock | 4.9k | $5.15 | $25k | | 06/03/2019 |
| 07/01/2014 | SALIX PHARMACEUTICALS LTD | SLXP | Payment of Exercise | Common Stock | 2k | $123.35 | $243.1k | | 07/01/2014 |
| 04/17/2014 | SALIX PHARMACEUTICALS LTD | SLXP | Grant | Common Stock | 19.8k | $100.66 | $2M | | 04/17/2014 |
| 01/08/2014 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 8k | $90.06 | $720.5k | | 01/08/2014 |
| 01/08/2014 | SALIX PHARMACEUTICALS LTD | SLXP | Exercise | Option to Buy Common Stock | 8k | $17.53 | $140.2k | | 01/08/2014 |
| 01/02/2014 | SALIX PHARMACEUTICALS LTD | SLXP | Payment of Exercise | Common Stock | 8.9k | $89.94 | $796.1k | | 01/02/2014 |
| 07/24/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 3k | $69.91 | $209.7k | | 07/24/2013 |
| 07/24/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 6k | $70.96 | $425.8k | | 07/24/2013 |
| 07/24/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 3k | $71.88 | $215.6k | | 07/24/2013 |
| 07/24/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Exercise | Option to Buy Common Stock | 12k | $17.53 | $210.4k | | 07/24/2013 |
| 07/01/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Payment of Exercise | Common Stock | 4.8k | $66.15 | $319.8k | | 07/01/2013 |
| 04/10/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Exercise | Option to Buy Common Stock | 13k | $17.53 | $227.9k | | 04/10/2013 |
| 04/10/2013 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 8.7k | $49.37 | $428.2k | | 04/10/2013 |
| 07/02/2012 | SALIX PHARMACEUTICALS LTD | SLXP | Payment of Exercise | Common Stock | 4.1k | $54.44 | $223.6k | | 07/02/2012 |
| 04/25/2012 | SALIX PHARMACEUTICALS LTD | SLXP | Grant | Common Stock | 20.7k | $0.00 | $0 | | 04/25/2012 |
| 02/13/2012 | SALIX PHARMACEUTICALS LTD | SLXP | Sale | Common Stock | 4.3k | $50.00 | $214.8k | | 02/13/2012 |
| 02/13/2012 | SALIX PHARMACEUTICALS LTD | SLXP | Exercise | Option to Buy Common Stock | 4.3k | $17.53 | $75.3k | | 02/13/2012 |